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WastewaterWe investigated the antimicrobial resistance proﬁle and the occurrence of Klebsiella pneumoniae
carbapenemase (KPC)–producing Gram-negative rods in sewage samples obtained from a Brazilian teaching
hospital and from the wastewater treatment plant (WWTP) that receives it for treatment. We identiﬁed
multidrug-resistant bacteria as well as KPC-2–producing Aeromonas spp. and several Enterobacteriaceae
species, including Kluyvera spp., in the hospital efﬂuent and in different sites of the WWTP. Most isolates
showed the blaKPC-2 gene harbored on a transposon that was carried by conjugative plasmids. The presence of
KPC production among Aeromonas spp., Kluyvera spp., and other Enterobacteriaceae indicates the adaptability
of such isolates to aquatic environments, not only in the hospital efﬂuent but also throughout the WWTP.
Although secondary treatment seems to decrease the amount of KPC producers in sewage, multidrug-
resistant isolates are continually disposed in the urban river. Thus, sewage treatment regulations are urgently
needed to decelerate the evolution of antimicrobial resistance beyond hospitals.oio à Pesquisa do Estado de São
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Klebsiella pneumoniae carbapenemase (KPC)–producing bacteria
has been isolated in microbiology laboratories from health institu-
tions worldwide. This β-lactamase is more often identiﬁed in
Klebsiella spp. clinical isolates, whereas it has been found among
other Enterobacteriaceae, Pseudomonas spp., and Acinetobacter spp. as
well (Walsh, 2010). The successful dissemination of KPC among
Gram-negative rods is attributed to the mobility of the genetic
elements associated with blaKPC, transposons, and broad-host-range
plasmids (Li et al., 2011; Naas et al., 2008).Differently fromwhat has been observed for New Dehli metallo-β-
lactamase (NDM)–producing bacteria in India, where researchers
evidenced their spread throughout the community (Walsh et al.,
2011), KPC-producing bacteria in Brazil is so far restricted to the
hospital environment (Gales et al., 2012). However, it is well
established that colonized and infected patients may disseminate
KPC-producing bacteria in excreta, which is usually accompanied by
active antimicrobials. In this context, the hospital sewage may
constitute the perfect scenario for exchange of resistance genes
between clinical pathogens and environmental bacteria due to the
presence of broad-spectrum antimicrobials along with such bacteria
(Brown et al., 2006; Martinez, 2009; Taylor et al., 2011). Indeed, KPC-
producing Enterobacteriaceae was identiﬁed from hospital efﬂuents
in Brazil and in China (Chagas, 2011; Zhang et al., 2012). However,
sanitary regulations were not developed considering the threat of
antimicrobial resistance. Thus, in Brazil, as in many other countries,
several hospitals do not treat their wastewater before disposing it into
the general sewage collecting system.
Wastewater treatment in large urban areas often applies the
activated sludge process. Brieﬂy, after a primary treatment consisting
of grading to remove bulkymaterials,wastewater is aerated. In this step,
microorganisms including many Gammaproteobacteria metabolize the
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and, after settling, the biomass is removed from the liquid stream
(Chasick, 1969; Kim and Aga, 2007). The secondarily treated sewage is
then discharged into rivers, estuaries, or oceans.
The bacterial load in the secondarily treated sewage is decreased
compared to the incoming sample. However, a signiﬁcant number of
bacteria still remain, especially those that are resistant to antimicro-
bials (Galvin et al., 2010; Kim and Aga, 2007). However, in several
previous papers regarding this issue, the resistance determinants
involved aswell as their genetic backgroundwere not disclosed. In the
present work, we assessed the presence of antimicrobial-resistant
Gram-negative rods, focusing on KPC producers, in the hospital
efﬂuent and through the wastewater treatment plant (WWTP) that
receives it for treatment.
2. Materials and methods
2.1. Sewage sampling and culture
A single wastewater sample was collected from the efﬂuent of a
tertiary teaching hospital located in São Paulo, Brazil, and also from
the afﬂuent, aeration tank, activated sludge, and efﬂuent of theWWTP
that receives this hospital efﬂuent. The plant is a secondary treatment
facility that serves 4.4 million people, located 35 km apart from the
hospital studied. During 2011, the plant showed an average hydraulic
loading of 9.7 L/s. Four waterways usually release the treated sewage
into an urban river. During the time the sewage samples were being
collected, the WWTP was working over its capacity and was unable to
treat all received sewage. Thus, one of the waterways was releasing
sewage that had only received primary treatment. Thus, 100 mL of
sewage samples collected from each waterway releasing secondarily
treated sewage was combined and named as “secondary efﬂuent”,
while the sample recovered from the remainingwaterwaywas named
“primary efﬂuent”. The samples were collected in 100-mL sterile
ﬂasks, conserved on ice during transportation, and then processed
within 6 h. A 500-μL aliquot of 1:50 diluted samples was inoculated in
chromogenic agar (BBL CHROMagar Orientation, Becton Dickinson,
Cockeysville, MD, USA) plates (140 × 15 mm) with or without
imipenem (1 μg/mL). To avoid the selection of only carbapenem-
resistant bacteria, the hospital sewage was only cultured without any
antimicrobial. From each plate, we subcultured a single colony among
those sharing the same appearance by visual inspection. Grown
colonies were then stored at – 20 °C in trypticase soy broth containing
15% glycerol (v/v).
2.2. Bacterial identiﬁcation
Bacterial genus was determined by matrix-assisted laser desorp-
tion ionization–time of ﬂight mass spectrometry (MALDI-TOF MS),
using the MALDI Biotyper 2.0 software (BrukerDaltonik, Bremen,
Germany), following the manufacturer's recommendations. KPC
producers had their identiﬁcation conﬁrmed by 16S rDNA sequencing.
Only Gram-negative rods were studied.
2.3. Susceptibility testing
The antimicrobial susceptibility proﬁle was assessed by the Clinical
Laboratory Standards Institute (CLSI) disk diffusion method and
conﬁrmed by agar dilution. Escherichia coli ATCC 25922 and Pseudomonas
aeruginosa ATCC 27853 were used as quality controls, and the results
were interpreted according to CLSI guidelines (CLSI, 2008, 2012a,b).
2.4. Investigation of blaKPC-2, its genetic context, and transfer
blaKPC detection was performed for all Gram-negative rods
recovered, as previously described (Yigit et al., 2001). The geneticcontext of blaKPC was determined by polymerase chain reaction (PCR)
using primers anchoring in blaKPC-2 and in the ISKpn6, ISKpn7, and
ISKpn8 structures and in the tnpA or tnpR genes, as previously
described (Li et al., 2011; Naas et al., 2008). Sequencing was carried
out using the Big Dye Terminator Cycle Sequencing (Applied
Biosystems, Carlsbad, CA, USA) and ABI PRISM 3130 (Applied
Biosystems) apparatus. Transfer of the blaKPC-2 gene was assessed by
mating out assays using the azide-resistant E. coli J-53 as the recipient
strain. Transconjugants were selected with ticarcillin (50 μg/mL) and
sodium azide (100 μg/mL), and the presence of blaKPC in such isolates
was conﬁrmed by PCR.
3. Results
A total of 312 Gram-negative bacilli were recovered from the
hospital sewage (n = 130, 41.6%) and from the WWTP (182, 58.4%).
The most represented family in the hospital sewage was Enterobac-
teriaceae (61.2%), followed by Aeromonadaceae (18.6%), which was
similar to that observed for the WWTP sewage samples cultured
under imipenem selective pressure (70.6% and 10.6%, respectively).
Samples from the WWTP cultured without imipenem showed the
opposite effect, with predominance of Aeromonadaceae (58.8%),
followed by Enterobacteriaceae (35.5%). Moraxellaceae and Pseudo-
monadaceae were isolated less frequently with culture conditions
applied in this study. The distribution of genera in the samples
evaluated varied according to the collection site and selective
pressure applied, as shown in Fig. 1.
Resistance rates observed among isolates obtained from sewage
samples are presented in Table 1. Overall, Aeromonas spp. recovered
in the absence of selective pressure showed a resistance rate above
50% for third-generation cephalosporins, except for ceftazidime
(33.3%). Aminoglycosides were the most active agents against
Aeromonas spp. (Table 1). When samples were cultured without
selective pressure, carbapenem-resistant Aeromonas spp. were only
obtained from the hospital efﬂuent. Eight Aeromonas spp. were
recovered from WWTP under imipenem selective pressure and
showed resistance rates of ≥50.0% for most tested antimicrobials,
with the exception of sulfamethoxazole–trimethoprim, ciproﬂoxacin,
and tetracycline (Table 1). It is important to emphasize that 42.9%,
22.2%, and 7.9% of Aeromonas spp. isolated from the WWTP without
selective pressure showed resistance to ceftriaxone, ceftazidime, and
ciproﬂoxacin, respectively.
Similarly to what was observed for Aeromonas spp., most
Enterobacteriaceae isolates recovered showed high resistance rates
to cefoxitin (60.7%) and to third-generation cephalosporins (resis-
tance rates ≥55.0%). Cefepime, imipenem, and meropenem showed a
similar activity, with 18.8%, 20.5%, and 16.2% resistance rates,
respectively. Resistance rates for ciproﬂoxacin, gentamicin, amikacin,
sulfamethoxazole–trimethoprim, and tetracycline were 12.8%, 17.1%,
29.1%, 22.6%, and 20.8%, respectively. The 53 enterobacterial isolates
recovered fromWWTP samples cultured in the presence of imipenem
showed higher resistance rates to carbapenems (above 95%) than to
ceftazidime and cefepime (both 49.1%). These isolates also showed
high resistance rates to aminoglycosides (56.6%), whereas only 17%
were resistant to ciproﬂoxacin (Table 1). Among Enterobacteriaceae
recovered from the WWTP in the absence of imipenem, 28.9%, 15.8%,
10.5%, and 7.9% were resistant to ceftriaxone, ceftazidime, ciproﬂox-
acin, and cefepime, respectively. Surprisingly, 2 Enterobacter spp.
isolates, 1 from the aeration tank and another from the primary
efﬂuent of theWWTP that were recovered without selective pressure,
showed either imipenem or meropenem resistance and were later
found to be KPC producers.
The antimicrobial resistance rates observed for Acinetobacter spp.
and Pseudomonas spp. are also presented in Table 1.
A total of 62 bacterial isolates showed the blaKPC-2 gene. These isolates
had their carbapenemase activity conﬁrmed by spectrophotometric


















Antimicrobial resistance rates for isolates recovered from sewage samples, according to the sampling site.
Group of isolates (n) Sampling site (ntotal/nIPMa) Resistance rates for selected antimicrobialsc (%)
TIC TIM FOX CRO CTX CAZ FEP ATM IPM MEM NA CIP CN AK TOB TE SXT
Aeromonas spp. All samples (n = 95/8) NDd NDd 58.9 52.6 54.7 34.7 15.8 23.2 10.5 10.5 NDd 16.8 17.9 13.7 NDd 13.7 32.6
Hospital efﬂuent (n = 24/0) NDd NDd 58.3 70.8 79.2 62.5 41.7 45.8 16.7 16.7 NDd 33.3 45.8 37.5 NDd 20.8 33.3
WWTPb Afﬂuent (n = 19/6) NDd NDd 68.4 68.4 63.2 52.6 10.5 21.1 21.1 21.1 NDd 21.1 21.1 10.5 NDd 15.8 42.1
Activated sludge
(n = 10/0)
NDc NDc 90.0 20.0 20.0 10.0 0.0 0.0 0.0 0.0 NDc 0.0 0.0 0.0 NDc 0.0 10.0
Aeration tank
(n = 20/0)
NDc NDc 50.0 45.0 50.0 20.0 5.0 15.0 0.0 0.0 NDc 15.0 0.0 0.0 NDc 20.0 35.0
Primary efﬂuent
(n = 15/2)
NDd NDd 46.7 60.0 60.0 20.0 13.3 26.7 13.3 13.3 NDd 6.7 13.3 13.3 NDd 0.0 20.0
Secondary efﬂuent
(n = 7/0)
NDd NDd 42.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NDd 0.0 0.0 0.0 NDd 14.3 57.1
Total WWTP
(n = 71/8)
NDd NDd 59.2 46.5 46.5 25.4 7.0 15.5 8.5 8.5 NDd 11.3 8.5 5.6 NDd 11.3 32.4
Enterobacteriaceae All samples (n = 170/53) 84.1 57.1 72.4 65.9 72.9 35.3 28.2 54.7 44.7 41.2 67.1 14.1 29.4 37.6 57.6 25.9 28.8
Hospital efﬂuent (79/0) 88.6 51.9 62.0 68.4 72.2 35.4 24.1 57.0 29.1 22.8 74.7 13.9 22.8 39.2 59.5 39.2 44.3
WWTP Afﬂuent (35/25) 85.7 77.1 94.3 71.4 80 45.7 42.9 62.9 71.4 71.4 60.0 20.0 51.4 45.7 65.7 14.3 17.1
Activated sludge
(3/0)
66.7 33.3 33.3 33.3 66.7 33.3 33.3 66.7 0.0 0.0 66.7 0.0 33.3 66.7 66.7 0.0 0.0
Aeration tank (10/3) 40.0 30.0 70.0 40.0 80.0 20.0 20.0 40.0 20.0 30.0 60.0 0.0 20.0 30.0 30.0 20.0 0.0
Primary efﬂuent
(34/23)
78.9 57.9 78.9 63.2 65.8 26.3 21.1 47.4 63.2 57.9 57.9 7.9 26.3 28.9 52.6 10.5 15.8
Secondary efﬂuent
(9/2)
77.8 33.3 33.3 44.4 44.4 33.3 33.3 22.2 22.2 22.2 44.4 33.3 11.1 11.1 33.3 22.2 22.2
Total WWTP (91/53) 80.2 61.5 81.3 63.7 73.6 35.2 31.9 52.7 58.2 57.1 60.4 14.3 35.2 36.3 56.0 14.3 15.4
Pseudomonas spp. All samples (n = 7/3) 71.4 71.4 NDd NDd NDd 71.4 85.7 42.9 42.9 42.9 NDd 42.9 42.9 0.0 85.7 NDd NDd
Hospital efﬂuent (n = 3) 66.7 66.7 NDd NDd NDd 66.7 66.7 33.3 0.0 0.0 NDd 0.0 0.0 0.0 100.0 NDd NDd
WWTP Afﬂuent (n = 2/2) 100.0 100.0 NDd NDd NDd 100.0 100.0 50.0 100.0 100.0 NDd 100.0 100.0 0.0 100.0 NDd NDd
Primary efﬂuent
(n = 2/1)
50.0 50.0 NDd NDd NDd 50.0 100.0 50.0 50.0 50.0 NDd 50.0 50.0 0.0 50.0 NDd NDd
Total WWTP
(n = 4/3)
75.0 75.0 NDd NDd NDd 75.0 100.0 50.0 75.0 75.0 NDd 75.0 75.0 0.0 75.0 NDd NDd
Acinetobacter spp. All samples (n = 27/4) 51.9 48.1 NDd 44.4 48.1 44.4 33.3 NDd 44.4 51.9 NDd 59.3 22.2 40.7 14.8 11.1 44.4
Hospital efﬂuent (n = 18) 66.7 61.1 NDd 44.4 50.0 44.4 38.9 NDd 55.6 55.6 NDd NDd 16.7 38.9 11.1 5.6 50.0
WWTP Afﬂuent (n = 1/0) 0.0 0.0 NDd 0.0 0.0 0.0 0.0 NDd 0.0 0.0 NDd 100.0 0.0 0.0 0.0 0.0 0.0
Activated sludge
(n = 1/0)
0.0 0.0 NDc 0.0 0.0 0.0 0.0 NDc 0.0 0.0 NDc 0.0 0.0 0.0 0.0 100.0 0.0
Aeration tank
(n = 4/2)
25.0 50.0 NDc 50.0 50.0 50.0 25.0 NDc 50.0 50.0 NDc 50.0 50.0 50.0 50.0 0.0 50.0
Secondary efﬂuent
(n = 3/2)
33.3 0.0 NDd 66.7 66.7 66.7 33.3 NDd 0.0 66.7 NDd 33.3 33.3 66.7 0.0 33.3 33.3
Total WWTP
(n = 9/4)
22.2 22.2 NDd 44.4 44.4 44.4 22.2 NDd 22.2 44.4 NDd 44.4 33.3 44.4 22.2 22.2 33.3
a nIMP describes the number of isolates that were recovered under selective pressure exerted by imipenem (1 mg/L).
b WWTP = Wastewater treatment plant.
c TIC = tidarcillin; TIM = ticarcillin/clavulanic acid; FOX = cefoxitin; CRO = ceftriaxone; CTX = cefotaxime; CAZ = ceftazidime; FEP = cefepime; ATM = aztreonam; ETP =
ertapenem; IPM = imipenem; MEM = meropenem; AK = amikacin; DN = gentamicin; TOB = tobramycin; NA = nalidixic acid; CIP = ciproﬂoxacin; TE = tetracycline; SXT =
sulfamethoxazole–trimethoprim.
d Not determined since there are no CLSI breakpoints available for interpreting susceptibility results.
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which were not susceptible to EDTA inhibition, indicating that
blaKPC-2 was properly expressed by all isolates (data not shown).
Among KPC-2 producers, representatives of the genera Klebsiella
spp. (41.9%), Enterobacter spp. (24.2%), Citrobacter spp. (8.1%),
Serratia spp. (4.8%), and, remarkably, also Raoultella spp. (6.4%),
Aeromonas spp. (6.4%), and Kluyvera spp. (8.1%) were observed.
KPC producers were present in the hospital efﬂuent (37.1%, n =
23) as well as in the WWTP (62.9%, n = 39).
The great majority of KPC-producing isolates from the WWTP
were recovered when samples were cultured under imipenem
selective pressure (56.5%, n = 35), mainly from the afﬂuent (48.7%,
n = 19) and from the primary efﬂuent (38.5%, n = 15), whereas 2
KPC-producing Klebsiella spp. were also isolated from the aeration
tank. Of note, 4 KPC-producing isolates were recovered from the
WWTP from samples cultured in the absence of imipenem: 1 Klebsiella
sp. from the afﬂuent, 1 Aeromonas sp. and 1 Enterobacter sp. from the
aeration tank, and 1 Enterobacter sp. from the activated sludge. None
of the KPC producers was isolated from the secondary efﬂuent. Thedistribution of KPC producers according to the sampling site and
selective pressure applied is depicted in Fig. 2.
The most active antimicrobial against KPC producers was
cefepime (35.4% susceptible; MIC50/90, 32 and 256 μg/mL), followed
by ciproﬂoxacin (33.8% susceptible; MIC50/90, 4 and 16 μg/mL),
gentamicin (24.2% susceptible; MIC50/90, 32 and N128 μg/mL), and
ceftazidime (19.3% susceptible; MIC50/90, 16 and 64 μg/mL). The
carbapenems were the least active drugs against KPC producers.
Although the potency of these drugs against this set of isolates was
similar (MIC50/90, 64 and N64 μg/mL for both), meropenem showed
a higher susceptibility rate than imipenem (12.9% and 4.8%
susceptible, respectively).
The genetic environment of blaKPC-2 was investigated for all KPC
producers. Forty-eight isolates harbored this gene as part of a Tn4401
structure (all Klebsiella spp. and Raoultella spp., most Enterobacter spp.
and Citrobacter, as well as 2 Aeromonas spp.), whereas 11 isolates had
the Tn3-tnpR/ISKpn8/blaKPC-2/ISKpn6 array (most Kluyvera spp. and 2
Aeromonas spp.). The genetic environment of blaKPC-2 could not be
identiﬁed for 2 Enterobacter spp. and 1 Serratia sp. Of note, KPC
Fig. 2. Distribution of KPC producers according to the sampling site and selective pressure applied. Sampling sites in the wastewater treatment plant include the afﬂuent, activated
sludge, aeration tank, and primary efﬂuent.
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(50%) or the Tn3-tnpR/ISKpn8/blaKPC-2/ISKpn6 array (36.3%), whereas
95% of KPC producers recovered from the WWTP had blaKPC harbored
on the Tn4401 transposon.
The blaKPC-2 gene of every isolate recovered from the hospital
sewage was successfully transferred by mating with E. coli J53 as the
recipient strain, indicating that it was located either on conjugative
or on mobilizable plasmids. blaKPC transfer by mating-out assays was
unsuccessful for only 7 KPC-producing isolates, which were recov-
ered from the WWTP (Enterobacter spp., n= 4; Klebsiella spp., n= 2;
and Aeromonas sp., n = 1). Further studies are needed to evaluate
whether these isolates carried blaKPC-2 on a nonconjugative plasmid
or on its chromosome.
4. Discussion
Hospital efﬂuents represent a concern for the environmental
dissemination of bacteria carrying critical antimicrobial resistance
determinants (Chagas, 2011). In addition to resistant bacteria,
hospital efﬂuents are also characterized by the presence of signiﬁcant
levels of active antimicrobials (Brown et al., 2006; Kim and Aga, 2007;
Verlicchi, 2012). Despite their speciﬁc nature, hospital efﬂuents are
frequently considered to be as pollutant as urban wastewaters, being
treated together with other urban efﬂuents and then discharged into
natural environments (Verlicchi, 2012).
The discharge of multidrug-resistant bacteria including KPC
producers into an urban river is worrisome, since these isolates
could persist in the environment and act as opportunistic pathogensand/or resistance reservoirs that could accelerate the evolution of
antimicrobial resistance in the community (Baquero et al., 2008; Kim
and Aga, 2007; Martinez, 2009). For instance, Brazilian researchers
have recently documented the presence of SPM-producing P.
aeruginosa in the same urban river where the sewage studied here
was discharged (Fontes et al., 2011).
In the present work, we have observed that Gram-negative rods
recovered from the hospital sewage showed the highest resistance
rates for most antimicrobials, which was expected for the reasons
mentioned above. However, a signiﬁcant portion of isolates recovered
from theWWTP in the absence of selective pressure was also resistant
to broad-spectrum antimicrobials. Since the hospital sewage was
extensively diluted in the WWTP, these remarkable ﬁndings may
suggest that domestic wastewater also contains a high amount of
bacteria that are resistant to broad-spectrum antimicrobials, likely
resulting from the selective pressure exerted by the use of
antimicrobials and sanitizers in the community. Even though KPC
producers were not recovered from secondarily treated sewage, it is
noticeable that neither primary nor secondary treatment was efﬁcient
in eliminating multidrug-resistant bacteria from sewage, as previous-
ly observed (Galvin et al., 2010; Kim and Aga, 2007).
We have identiﬁed for the ﬁrst time KPC production among
Aeromonas spp. and Kluyvera spp., species considered to be predom-
inantly environmental and notorious reservoirs of resistance genes
(Picao et al., 2008; Rodriguez et al., 2004). During the period of study,
neither Aeromonas spp., Raoultella spp., nor Kluyvera spp. clinical
isolates that produce KPC were recovered from clinical specimens by
our hospital clinical microbiology laboratory. Since blaKPC-2 was
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Aeromonas spp., Raoultella spp., and Kluyvera spp.might have acquired
the blaKPC-2 in the hospital's sewage, which could have been favored
by the selective pressure exerted by the antimicrobials usually
present in such location (Brown et al., 2006). Of note, KPC-producing
Aeromonas spp. was also recovered from the WWTP studied,
indicating that this genus can represent a blaKPC reservoir in the
environment. The study design conducted in the present work was
not quantitative. Although the real magnitude of this phenomenon
has yet to unravel, the presence of blaKPC in bacteria considered
predominantly environmental is remarkable. In addition, the persis-
tence of KPC-producing Enterobacteriaceae in sewage and in aquatic
environments deserves attention.
Analysis of the genetic environment of blaKPC-2 showed that the
great majority of isolates carried this gene on conjugative or
mobilizable plasmids, harbored on a Tn4401 structure. We speculate
that this ﬁnding may reﬂect that plasmids carrying this transposon
may encode functions conferring advantageous features for bacteria
living in environments such as the one evaluated here, whichmay not
be true for plasmids carrying the Tn3-tnpR/ISKpn8/blaKPC-2/ISKpn6
array. These ﬁndings may encourage researchers to investigate this
phenomenon and increase our understanding regarding the genetic
elements driving the evolution of antimicrobial resistance in natural
environments as well as in the community.
In an era when antimicrobial resistance evolution and dissemina-
tion are not accompanied by the development of new antimicrobials,
controlling the dissemination of antimicrobial-resistant bacteria is
absolutely necessary. In this context, hospital sewage treatment
regulations regarding the spread of resistance bacteria and/or genes
could contribute to decelerating the antimicrobial resistance evolu-
tion beyond hospitals.
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